improvement of nLUTD within 48 hours. Both neurogenic patients were completely dry two months post-op; UI and nocturia disappeared (bladder diary). Both patients stopped CTNM due to the progression of their comorbidity, though a causal correlation could not be drawn. After 1.5 years the electrode of one patient migrated through the implantation path. In the second group, the male was excluded due to lack of improvement and required an alternative treatment. Five female iOAB patients documented major improvements in their bladder diaries. UUI episodes significantly decreased (base: 2.1/day vs. 2.5/month 6 months post-op) and nocturia vanished. Mean voided volume significantly increased by 70ml, without or increased PVR. In the five iOAB patients, all implants are currently in place and their efficacy confirmed.
improvement of nLUTD within 48 hours. Both neurogenic patients were completely dry two months post-op; UI and nocturia disappeared (bladder diary). Both patients stopped CTNM due to the progression of their comorbidity, though a causal correlation could not be drawn. After 1.5 years the electrode of one patient migrated through the implantation path. In the second group, the male was excluded due to lack of improvement and required an alternative treatment. Five female iOAB patients documented major improvements in their bladder diaries. UUI episodes significantly decreased (base: 2.1/day vs. 2.5/month 6 months post-op) and nocturia vanished. Mean voided volume significantly increased by 70ml, without or increased PVR. In the five iOAB patients, all implants are currently in place and their efficacy confirmed.
CONCLUSIONS: CTNM offers a promising treatment option using a novel chronic implantable device using an external charger. The new minimalinvasive technology might revolutionize neuromodulation and offers those patients suffering from refractory OAB an opportunity to perform CTNM over several hours, even while sleeping with low or no stimulation related morbidities.
Source of Funding: StimGuard supplied the stimulation devices.
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URODYNAMIC FINDINGS OF PATIENTS WITH BRAIN TUMOR CLASSIFIED BY LOCATION OF AFFECTED AREA Hee Seo Son*, Mark Benson Gamo, Jongsoo Lee, Jong Won Kim, Seoul, Korea, Republic of; Sang-Hyeon Cheon, Ulsan, Korea, Republic of; Ju Tae Seo, Jang Hwan Kim, Seoul, Korea, Republic of INTRODUCTION AND OBJECTIVES: With advancement of treatment modalities, the survival of patients with brain tumor has been increased, and the management of lower urinary tract symptom of brain tumor patients emerged as a new challenge. Although several brain imaging studies have been introduced with healthy brain parenchyma, identifying fundamental brain region involved, the correlation of each areas is not proved distinctively. Especially, the effect of intracranial space occupying lesions on bladder and urethra is not clearly demonstrated until now. We have evaluated urological symptoms and urodynamic findings of patients with brain tumor, and made comparison of the urodynamic patterns according the affected brain areas.
METHODS: Brain tumor patients with urological symptom who received urodynamic test at our tertiary referral center from May 2007 to March 2016 were evaluated. To minimize confounding variables, patients with accompanying degenerative neurological disorders, spinal cord injury, diabetes mellitus, prostatic hyperplasia, history of pelvic organ surgery were excluded. And patients with multiple brain lesions were also excluded. The localization of brain tumor was based on the magnetic resonance imaging or computed tomography imaging taken same time of urodynamic study.
RESULTS: Finally, twenty six patients (male 8 female 18) were assessed. The median age at urodynamic study was 46.5 (21.3~76.5) years old. Twenty four patients received urodynamic study at median period of 3.6 (0.9~74.3) months after brain surgery, and two patients had not received operation at the time of urodynamic study. Involuntary detrusor contraction was observed in 13 (50%) patients, acontractile detrusor was observed in 7 (36.9%) patients, and detrusor sphincter dyssynergia was observed only in one patient with frontal lobe tumor. The urological symptom and urodynamic findings showed different pattern according to the affected territory (Figure 1.) CONCLUSIONS: We could observe diverse urodynamic patterns according the affected areas. Our results suggest complexity of micturition circuit in central nervous system. Further study with large cohort in correlation with functional brain imaging might solve the mysterious role of brain on bladder, suggesting management guide according to the affected brain area. Vol. 197, No. 4S, Supplement, Tuesday, May 16, 2017 THE JOURNAL OF UROLOGY â e1265
Source of Funding: none

